VASC PHARMACOL 润色咨询

VASCULAR PHARMACOLOGY

出版年份：2002 年文章数：963 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：1.9% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=563742, encodeId=a633563e4217, content=审稿速度:2.0<br>经验分享：这个杂志年发文量很少，对药理学要求比较高，质量还不错。一审周期2个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=645a2234601, createdName=道济天下, createdTime=Wed Nov 28 19:22:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848396, encodeId=46ad848396bb, content=这个杂志年发文量很少，对药理学要求比较高，质量还不错。一审周期2个月左右。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d3b5414077, createdName=ms982570025122324, createdTime=Wed Nov 28 19:17:31 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561765, encodeId=1ab0561e6534, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：这个杂志实在太慢了，一审两个月还行，二审三个月了也没变化，太耽误时间了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/26/e4f43f86b37fd147630d00df5879198a.jpg, createdBy=39792054960, createdName=Tiandy, createdTime=Mon Oct 08 00:00:00 CST 2018, time=2018-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497534, encodeId=87d749e534da, content=跨过2分了，明年会不会再略冲冲，很有希望, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=pingjian888, createdTime=Mon Jul 01 11:36:00 CST 2013, time=2013-07-01, status=1, ipAttribution=)]
    2018-11-28 道济天下

    审稿速度:2.0
    经验分享：这个杂志年发文量很少，对药理学要求比较高，质量还不错。一审周期2个月左右。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=563742, encodeId=a633563e4217, content=审稿速度:2.0<br>经验分享：这个杂志年发文量很少，对药理学要求比较高，质量还不错。一审周期2个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=645a2234601, createdName=道济天下, createdTime=Wed Nov 28 19:22:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848396, encodeId=46ad848396bb, content=这个杂志年发文量很少，对药理学要求比较高，质量还不错。一审周期2个月左右。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d3b5414077, createdName=ms982570025122324, createdTime=Wed Nov 28 19:17:31 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561765, encodeId=1ab0561e6534, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：这个杂志实在太慢了，一审两个月还行，二审三个月了也没变化，太耽误时间了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/26/e4f43f86b37fd147630d00df5879198a.jpg, createdBy=39792054960, createdName=Tiandy, createdTime=Mon Oct 08 00:00:00 CST 2018, time=2018-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497534, encodeId=87d749e534da, content=跨过2分了，明年会不会再略冲冲，很有希望, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=pingjian888, createdTime=Mon Jul 01 11:36:00 CST 2013, time=2013-07-01, status=1, ipAttribution=)]
    2018-11-28 ms982570025122324

    这个杂志年发文量很少，对药理学要求比较高，质量还不错。一审周期2个月左右。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=563742, encodeId=a633563e4217, content=审稿速度:2.0<br>经验分享：这个杂志年发文量很少，对药理学要求比较高，质量还不错。一审周期2个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=645a2234601, createdName=道济天下, createdTime=Wed Nov 28 19:22:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848396, encodeId=46ad848396bb, content=这个杂志年发文量很少，对药理学要求比较高，质量还不错。一审周期2个月左右。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d3b5414077, createdName=ms982570025122324, createdTime=Wed Nov 28 19:17:31 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561765, encodeId=1ab0561e6534, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：这个杂志实在太慢了，一审两个月还行，二审三个月了也没变化，太耽误时间了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/26/e4f43f86b37fd147630d00df5879198a.jpg, createdBy=39792054960, createdName=Tiandy, createdTime=Mon Oct 08 00:00:00 CST 2018, time=2018-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497534, encodeId=87d749e534da, content=跨过2分了，明年会不会再略冲冲，很有希望, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=pingjian888, createdTime=Mon Jul 01 11:36:00 CST 2013, time=2013-07-01, status=1, ipAttribution=)]
    2018-10-08 Tiandy

    审稿速度:12.0 | 投稿命中率:50.0
    经验分享：这个杂志实在太慢了，一审两个月还行，二审三个月了也没变化，太耽误时间了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=563742, encodeId=a633563e4217, content=审稿速度:2.0<br>经验分享：这个杂志年发文量很少，对药理学要求比较高，质量还不错。一审周期2个月左右。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=267, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=645a2234601, createdName=道济天下, createdTime=Wed Nov 28 19:22:00 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=848396, encodeId=46ad848396bb, content=这个杂志年发文量很少，对药理学要求比较高，质量还不错。一审周期2个月左右。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=208, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d3b5414077, createdName=ms982570025122324, createdTime=Wed Nov 28 19:17:31 CST 2018, time=2018-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561765, encodeId=1ab0561e6534, content=审稿速度:12.0 | 投稿命中率:50.0<br>经验分享：这个杂志实在太慢了，一审两个月还行，二审三个月了也没变化，太耽误时间了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=433, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/26/e4f43f86b37fd147630d00df5879198a.jpg, createdBy=39792054960, createdName=Tiandy, createdTime=Mon Oct 08 00:00:00 CST 2018, time=2018-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=497534, encodeId=87d749e534da, content=跨过2分了，明年会不会再略冲冲，很有希望, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=532, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=pingjian888, createdTime=Mon Jul 01 11:36:00 CST 2013, time=2013-07-01, status=1, ipAttribution=)]
    2013-07-01 pingjian888

    跨过2分了，明年会不会再略冲冲，很有希望

    0

共5条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分